Immuneering Corporation

Historical 13F Holders

Symbol
IMRX
CUSIP
45254E107
All holders as of
Q2 2026
Type
Equity
Class
CLASS A COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 45254E107 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G
14.5% 10/7/2025
Event 9/30/2025
BlackRock, Inc. 13G 6.7% 7/28/2026
Event 6/30/2026
Benjamin J. Zeskind 13G/A 6.6% 1/22/2026
Event 12/31/2025
HBM Healthcare Investments (Cayman) Ltd. 13G 5.7% 10/3/2025
Event 9/26/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Empery Asset Management, LP 13G/A
4.99% 1/15/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 199 $815.00
2026 Q2 118 34.4 M $172 M
2026 Q1 101 29.3 M $154 M
2025 Q4 94 31.8 M $209 M
2025 Q3 70 26.1 M $182 M
2025 Q2 41 3.85 M $13.0 M
2025 Q1 36 4.50 M $6.84 M
2024 Q4 43 4.30 M $9.32 M
2024 Q3 40 4.36 M $10.9 M
2024 Q2 63 9.64 M $12.3 M
2024 Q1 55 12.0 M $34.6 M
2023 Q4 56 16.7 M $122 M
2023 Q3 53 16.9 M $130 M
2023 Q2 50 17.3 M $176 M
2023 Q1 36 11.8 M $115 M
2022 Q4 36 11.8 M $57.1 M
2022 Q3 33 12.1 M $172 M
2022 Q2 38 12.1 M $65.7 M
2022 Q1 52 13.7 M $88.7 M
2021 Q4 39 13.2 M $211 M
2021 Q3 39 12.1 M $316 M